Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 97, Issue 5, 2004, Pages 613-619

  Edwards, Paul C ^a   Bhuiya, Tawfiqul ^a   Kelsch, Robert D ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; PARAFFIN; PROTEIN ANTIBODY; PROTEIN P63;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOMA; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LACRIMAL DUCT; LACRIMAL GLAND DISEASE; MALE; MORPHOGENESIS; MYOEPITHELIUM CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALIVARY GLAND; SALIVARY GLAND TUMOR; SEQUENCE HOMOLOGY; STEM CELL;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA, ADENOID CYSTIC; CELL DIFFERENTIATION; CELL NUCLEUS; CONNECTIVE TISSUE; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; MUSCLE, SMOOTH; PHOSPHOPROTEINS; SALIVARY GLAND NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 2442509820     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2003.09.010     Document Type: Article

References (25)

1. Reis-Filho J.S., Schmitt F.C. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol. 9:2002;280-289
2. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., et al. P63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 398:1999;714-718
3. Flores E.R., Tsai K.Y., Crowley D., et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 416:2002;560-564
4. Nylander K., Dabelsteen E., Hall P.A. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med. 29:2000;413-425
5. Strano S., Rossi M., Fontemaggi G., et al. From p63 to p53 across p73. FEBS Lett. 490:2001;163-170
6. Yang A., Kaghad M., Caput D., McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 18:2002;90-95
7. Mills A.A., Zheng B., Wang X.J., Vogel H., Roop D.R., Bradley A. P63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 398:1999;708-713
8. Pellegrini G., Dellambra E., Golisano O., et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci. 98:2001;3156-3161
9. Brunner H.G., Hamel B.C., van Bokhoven H. The p63 gene in EEC and other syndromes. J Med Gen. 39:2002;377-381
10. Brunner H.G., Hamel B.C., van Bokhoven H. P63 gene mutations and human developmental syndromes. Am J Med Gen. 112:2002;284-290
11. Barbareschi M., Pecciarini L., Cangi M.G., et al. P63, a p53 homologue is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol. 25:2001;1054-1060
12. Glickman J.N., Yang A., Shahsafaei A., McKeon F., Odze R.D. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol. 32:2001;1157-1165
13. Di Como C.J., Urist M.J., Babayan I., et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 8:2002;494-501
14. Kaufmann O., Fietze E., Mengs J., Dietel M. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 116:2001;823-830
15. Parson J.K., Gage W.R., Nelson W.G., De Marzo A.M. P63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Urology. 58:2001;619-624
16. Krane J.F., McKeon F., Faquin W.C. Expression of p63, a p53 homologue, in normal and neoplastic salivary gland. [abstract] Mod Pathol. 14:2001;151A. Abstract 881
17. Ellis G.L., Auclair P.L. Tumors of the salivary gland. Atlas of tumor pathology. Third series. Fascicle 17. 1995;Armed Forces Institute of Pathology, Washington (DC). pp. 102-128, 333-49
18. Jones H., Moshtael F., Simpson R.H. Immunoreactivity of α-smooth muscle actin in salivary gland tumors: a comparison with S-100 protein. J Clin Pathol. 45:1994;938-940
19. Regezi J.A., Zarbo R.J., Stewart J.C., Courtney R.M. Polymorphous low-grade adenocarcinoma of minor salivary gland. A comparative histologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 71:1991;469-475
20. Prasad A.R., Savera A.T., Gown A.M., Zarbo R.J. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med. 123:1999;801-806
21. Araujo V., Sousa S., Jaeger M., et al. Characterization of the cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy. Oral Oncol. 35:1999;164-172
22. Guccion J.G., Redman R.S. Canalicular adenoma of the buccal mucosa: an ultrastructural and histochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 61:1986;173-178
23. Zarbo R.J., Prasad A.R., Regezi J.A., Gown A.M., Savera A.T. Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. Arch Pathol Lab Med. 124:2000;401-405
24. Weber A., Langhanki L., Schutz A., et al. Expression patterns of p53, p63, and p73 in benign salivary gland tumors. Vircows Archiv. 441:2002;428-436
25. Bilal H., Handra-Luca A., Bertrand J., Fouret P. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem. 51:2003;133-139